We are live on ! Find out more
COEPW

Coeptis Therapeutics Warrants
COEPW

Delisted

COEPW was delisted on the 24th of April, 2026.

Back to rankings

18 hedge funds and large institutions have $286K invested in Coeptis Therapeutics Warrants in 2023 Q1 according to their latest regulatory filings, with 2 funds opening new positions, 2 increasing their positions, 4 reducing their positions, and 4 closing their positions.

New
Increased
Maintained
Reduced
Closed

5% more capital invested

Capital invested by funds: $272K → $286K (+$14.3K)

14% less funds holding

Funds holding: 21 → 18 (-3)

50% less first-time investments, than exits

New positions opened: 2 | Existing positions closed: 4

50% less repeat investments, than reductions

Existing positions increased: 2 | Existing positions reduced: 4

Holders
18
Holders Change
-3
Holders Change %
-14.29%
% of All Funds
0.29%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
2
Increased
2
Reduced
4
Closed
4
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
CF
Cantor Fitzgerald
New York
+$13.7K
2
Susquehanna International Group
Susquehanna International Group
Pennsylvania
+$12.9K
3
ICM
Ionic Capital Management
New York
+$12.9K
4
RCM
Radcliffe Capital Management
Pennsylvania
+$4.61K

Top Sellers

Rank Fund Capital Flow
1
MC
Meteora Capital
Florida
-$18.5K
2
OCAM
Owl Creek Asset Management
New York
-$9.49K
3
Walleye Capital
Walleye Capital
New York
-$7.61K
4
WAM
Wolverine Asset Management
Illinois
-$2.23K
5
VF
Virtu Financial
New York
-$2K

COEPW Hedge Fund Activity: Q1 2023 in Review

18 of the 6,284 institutional investors tracked by Wall St. Rank reported a position in Coeptis Therapeutics Warrants (COEPW) for Q1 2023, worth a combined $286K — up 5.3% from $272K a quarter earlier.

Sellers outnumbered buyers: 4 funds closed out of COEPW and 2 opened new positions — a net loss of 2 holders — while 4 trimmed existing stakes and 2 added.

The largest buyer was Cantor Fitzgerald, opening a new position worth an estimated $13.7K. The largest seller was Meteora Capital, cutting an estimated $18.5K.

  • 18 institutional investors held Coeptis Therapeutics Warrants (COEPW) as of Q1 2023, down from 21 in Q4 2022.
  • Funds reported $286K of Coeptis Therapeutics Warrants stock for Q1 2023, up 5.3% quarter-over-quarter.
  • 2 funds opened new Coeptis Therapeutics Warrants positions in Q1 2023 and 4 closed out, a net change of -2 holders.
  • The largest Coeptis Therapeutics Warrants buyer in Q1 2023 was Cantor Fitzgerald, an estimated $13.7K added.
  • The largest Coeptis Therapeutics Warrants seller in Q1 2023 was Meteora Capital, an estimated $18.5K sold.

Based on aggregated 13F filings for Q1 2023.